Clinical trial reportProstate cancer and prostatic diseasesPublished
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Prostate cancer and prostatic diseases
- Published
- Topic
- Disease research
- Subject terms
- Humans; Neoplasm Metastasis; Prednisone; Antineoplastic Combined Chemotherapy Protocols; Prognosis; Aged; Middle Aged; Male; Prostatic Neoplasms, Castration-Resistant; Biomarkers, Tumor; Bevacizumab; Docetaxel
- PubMed ID
- 38347114
- PubMed Central ID
- PMC11317541
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked